Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation [EARLY_Phase 1]
Clinical trial update on a Phase 1 study examining discontinuation of anticoagulation after successful catheter ablation in atrial fibrillat…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation
A prospective validation study is being conducted to evaluate an AI-based algorithm for predicting paroxysmal atrial fibrillation; the trial…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Prediction of Stroke Risk in Patients with Atrial Fibrillation Based on Chest CT Images
This clinical trial update investigates whether chest CT images can predict stroke risk in patients with atrial fibrillation, with the study…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Impact of Sleep Quality on Outcomes After Cardiac Surgery [NA]
A clinical trial evaluating whether sleep quality influences outcomes after cardiac surgery, including postoperative atrial fibrillation and…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Left Atrial Function After Pulsed Field Ablation of Atrial Fibrillation
Clinical trial evaluating left atrial function after pulsed field ablation for atrial fibrillation; the study is currently not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Exercise Effects on Atrial Fibrillation [NA]
This clinical trial investigates whether exercise affects atrial fibrillation. The study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2 [Phase 2]
Milestone Pharmaceuticals reports Phase 2 ReVeRA-201 results for etripamil in atrial fibrillation; the study has completed and results have …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs Warfarin)
This update reports the completed status of CNODES' study comparing direct oral anticoagulants to warfarin in patients with atrial fibrillat…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Renal Function and Hemolysis After Pulsed-field Ablation for Atrial Fibrillation
This clinical trial update discusses preliminary observations of renal function changes and hemolysis associated with pulsed-field ablation …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predictor of Recurrence After a Single Ablation Procedure Using a PVI-Only Strategy [NA]
Completed clinical trial evaluating high-density wave mapping to predict atrial fibrillation recurrence after a single ablation using a pulm…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With FIRM Guided Procedures [NA]
This clinical trial update reports the results of a randomized evaluation of redo ablation procedures for atrial fibrillation using FIRM-gui…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ReAHEAD: A Study to Find Out Whether Education Improves Adherence to Dabigatran in People With Atrial Fibrillation Who Are Younger Than 75 Years
The ReAHEAD trial, a Boehringer Ingelheim study in atrial fibrillation patients under 75, evaluated whether education improves adherence to …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot) [Phase 3]
Phase 3 IMPROVE-PVI Pilot trial comparing short-course colchicine to placebo after pulmonary vein isolation for atrial fibrillation has comp…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation
The trial evaluates whether inflammatory indexes and gene scores can predict atrial fibrillation risk and is currently recruiting at Vrinnev…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Myocardial Bridging in Obstructive Hypertrophic Cardiomyopathy
A completed clinical trial from Chinese Academy of Medical Sciences/Fuwai Hospital evaluating myocardial bridging in obstructive hypertrophi…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation [Phase 4]
Phase 4 trial comparing low-dose versus standard-dose rivaroxaban in elderly patients with atrial fibrillation; the study is currently recru…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: DUTCH Weight Control in Atrial Fibrillation Study [Phase 4]
Phase 4 clinical trial update investigating weight control in patients with atrial fibrillation and obesity, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: PrOgnosis Following Esophageal FisTula FormaTion in Pts Undergoing CathetER Ablation for AF Study
This completed clinical trial updates prognosis after atrioesophageal fistula formation in patients undergoing catheter ablation for atrial …
-
CLINICAL_TRIALS other · 2024-09-19Clinical Trial Update: Dispersion Stability [NA]
A clinical trial in Marseille, France focusing on atrial fibrillation is currently active but not recruiting.
-
FDA approval · 2024-09-12FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for diltiazem hydrochloride by Mylan Pharmaceuticals Inc. under ANDA074910, indicating regulatory ap…
-
FDA approval · 2024-09-11FDA Approved: AMIODARONE HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals)
FDA approved the original application for Amiodarone hydrochloride (Slate Run Pharmaceuticals) as a generic antiarrhythmic agent.
-
FDA approval · 2024-09-09FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride (Hospira, Inc.), confirming it as an approved generic drug under an ANDA…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients [NA]
A Cairo University-sponsored trial is evaluating whether education level affects clinical outcomes in patients with atrial fibrillation and …
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation
A multicenter registry study assessing multimodal cardiac imaging in patients with atrial fibrillation, including AI-assisted echocardiograp…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation [NA]
A completed clinical trial update evaluating transatrial pericardial separation to improve the safety of subxiphoid pericardial access durin…